Pharma firms turn to hybrid sourcing

New research reveals that pharma firms are increasingly turning to hybrid sourcing models, deepening global sourcing adoption across the value chain to include drug development and research, supply chain, data management and analytics functions.

This entry was posted in cat-news. Bookmark the permalink.

Comments are closed.